Global Single Cell Analysis Market By Type (Consumable, Instrument), By Application (Cancer Treatment, Neurology, Stem Cell), By Region, And Segment Forecasts, 2023 to 2032

Market Overview:

The global single-cell analysis market in the healthcare system is witnessing significant growth owing to technological advancements, increasing research activities in genomics and proteomics, and the rising prevalence of chronic diseases. Single-cell analysis involves the study of individual cells to understand their behaviour, functions, and interactions within complex biological systems. This approach has gained immense popularity in the field of healthcare due to its ability to provide detailed insights into cellular heterogeneity and disease mechanisms.

The single-cell analysis market was valued at USD 3.14 billion in 2024 and is expected to reach USD 9.92 billion by 2029, growing at a CAGR of 15.6% during the forecast period of 2024-2029. The surge in various cancer cases leading to investment in cancer research and the rising prevalence of HAIs across the world is expected to add to the projected growth of almost 31 million by 2040. The COVID-19 outbreak has positively affected the industry as governments of the world increased funding for vaccine development and production which resulted in the use of single-cell analysis products for COVID-19 research.

Premium Insights:

• Single-cell analysis enables researchers to uncover rare cell populations, identify novel biomarkers, and develop personalised therapies, driving its adoption in the healthcare sector.

•  Technological advancements such as microfluidics, next-generation sequencing (NGS), and high-content screening are enhancing the accuracy and efficiency of single-cell analysis techniques.

• The integration of artificial intelligence (AI) and machine learning algorithms is revolutionising data analysis, enabling researchers to extract meaningful insights from large-scale single-cell datasets.

  

Global Single-Cell Market Dynamics

Drivers: demand for personalised medicine, advancements in omics technologies, growing focus on stem cell research

-Rising demand for personalised medicine is a particular factor in this market as single-cell analysis facilitates the identification of patient-specific molecular signatures, enabling the development of targeted therapies tailored to individual needs

- Advancements in Omics technologies like continuous innovation in genomics, transcriptomics, proteomics, and metabolomics are fueling the adoption of single-cell analysis techniques for comprehensive molecular profiling

- growing focus on stem cell research due to single-cell analysis playing a crucial role in characterising stem cell populations, understanding their differentiation pathways,and evaluating their therapeutic potential in regenerative medicine 

Restraints: High costs and Technical limitations in the market

• High costs are a major restraint, due to financial limitations, many research and academic laboratories cannot afford the expensive instruments, which is predicted to hinder market expansion.

• Several technical limitations are anticipated to pose a challenge to the single-cell analysis market.

Opportunities:  Technological advancements, increased application and research, contribution through government funding and investments by specific industries.

-The integration of single-cell analysis with emerging technologies such as spatial transcriptomics and multi-omics approaches presents lucrative opportunities for market players. Additionally, the expanding applications of single-cell analysis in drug discovery, cancer research, and immunotherapy hold promise for future market growth.

-The pharmaceutical and biotechnology industries are expected to create significant opportunities for the market due to technological advancements in single-cell analysis products and an increase in research and development efforts. 

-The market is also expected to grow due to a rise in government funding and investments in the medical diagnostics sector.

Market by Single-cell Type Insights

• Based on product, the consumables segment held a dominant market share of 57% in 2023 and is projected to experience the fastest growth rate of 19.7%. The consumables are sub-segmented into beads, reagents, microplates, assay kits and other consumables. This prominent share can be attributed to several factors, such as the growing popularity of assay kits, the frequent purchases of buffers and reagents, the widespread use of isolation products and the extensive use of cell sorting beads. This market is expanding as a result of the increasing frequency of target diseases and the ongoing need for consumables necessary for scientific assays. The installation of new instruments, the replacement of old ones and associated services are the main sources of revenue generation for the instruments segment

• The market was dominated by the cancer segment in 2023, which also held the largest share (37%). With a CAGR of 19.96% from 2024 to 2033, it is anticipated to hold its position as the segment with the fastest rate of growth. Single-cell analysis has become an essential diagnostic tool for cancer cells, providing precise identification of genetic variations, conditions for cell proliferation, rates of mutation, and types of cells.

• Workflow-wise, for the year 2023, with a significant revenue share of 40%, the single-cell isolation and library preparation segment held dominance. Single-cell analysis has many uses, which has raised the demand for products related to cell isolation and library preparation, such as kits and reagents. Furthermore, a large number of industry participants provide a range of products for single-cell isolation, including flow cytometry, microfluidics, microdissection of fixed tissue samples, and FACS and MACS for heterogeneous cell suspensions. 

Market by End Use Insights 

• Research laboratories accounted for the largest share of the single-cell market, driven primarily by the growing emphasis on fundamental research, academic collaborations, and government funding initiatives. It is further driven by the advent of spatial genomics, which has expedited single-cell analysis in research. Moreover, the creation of novel instruments to surmount constraints in research is fostering market expansion. 

Market by Region Insights

Based on the regional coverage, the global single-cell market is divided into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa ( MEA). Asia Pacific is expected to show the highest growth rate, attributed to expanding biotechnology and pharmaceutical sectors, rising adoption of advanced healthcare technologies, and growing awareness about personalised medicine. North America constitutes the largest market in terms of the global single regional market share, due to the presence of key industry players, robust research infrastructure, and favourable government initiatives supporting genomics and precision medicine.

Competitive Scenario

Major players operating in the Global single-cell market are Thermo Fisher Scientific, Inc., QIAGEN NV, Bio-Rad Laboratories Inc., Illumina Inc., F. Hoffmann-La Roche Ltd, Fluidigm Corporation, Merck KGaA,10x Genomics, Inc., BGI, Novogene Corporation. 

Scope of Work- Global Single Cell Analysis Market

Key Market Developments

• October 2023- 10x Genomics announced the launch of its Visium Spatial Gene Expression Solution, enabling simultaneous analysis of gene expression and tissue morphology at single-cell resolution.

• July 2023- To provide researchers with the highest-quality results from next-generation sequencing (NGS) runs, QIAGEN introduced the QIAseq Normalizer Kits, which are quick, easy, and reasonably priced.

• September 2023- Illumina Inc. presents a streamlined workflow in partnership with Singleron Biotechnologies, utilising an Illumina NextSeq 2000 instrument to sequence a Singleron GEXSCOPE single cell library, followed by an automatic launch of onboard DRAGEN Single Cell RNA analysis.

•  December 2023- A patent for an automated single-cell capture and processing system and method has been awarded to Bio-Rad Laboratories. To support sample processing elements and carry out workflows for single-cell processing, such as antibody detection and mRNA detection, the system consists of a deck, gantry, and base.

• March 2024- BD (Becton, Dickinson and Company) completed the acquisition of Berkeley Lights, Inc., a leader in digital cell biology, to strengthen its single-cell analysis capabilities and portfolio offerings.

Frequently Asked Questions (FAQs) regarding this market. 

1. What are the key applications of single-cell analysis in healthcare?

Ans. Single-cell analysis is utilized in various healthcare applications such as personalized medicine, cancer research, stem cell characterization, drug discovery, and immunotherapy.

2. What are the emerging trends in the single-cell analysis market?

Ans. Emerging trends include the integration of spatial transcriptomics, multi-omics approaches, and artificial intelligence algorithms to enhance the accuracy and efficiency of single-cell analysis techniques.

3. What is the future market value for the Global Single Cell Market?

           Ans. The market is valued at USD 9.90 billion by 2029

4. Which is the largest region during the forecast period in the Global SIngle-Cell 

Market?

          Ans. North America is the largest region with a revenue share of 38 % in 2023